Alfasigma’s Nordic Pharma deal is more than a bolt-on: why the €190m business could reshape its specialty-care strategy
Alfasigma will acquire Nordic Group, adding Nordimet, €190 million in revenue and broader specialty-care operations across Europe, Canada and Japan.